Welcome to LookChem.com Sign In|Join Free
  • or
N,N-dimethyl-3,3-diphenylpropan-1-amine is a chemical compound with the molecular formula C17H21N. It is a secondary amine derivative characterized by a central amine group flanked by two substituents, one being a dimethyl group and the other a diphenylpropan group. N,N-dimethyl-3,3-diphenylpropan-1-amine is known for its potential applications in various fields, particularly in pharmaceuticals and neurochemistry.

4646-55-3

Post Buying Request

4646-55-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4646-55-3 Usage

Uses

Used in Pharmaceutical Synthesis:
N,N-dimethyl-3,3-diphenylpropan-1-amine is utilized as a precursor in the synthesis of various pharmaceuticals and organic compounds. Its unique structure allows it to serve as a building block for the development of new drugs with specific therapeutic properties.
Used as an Antidepressant:
In the field of psychopharmacology, N,N-dimethyl-3,3-diphenylpropan-1-amine has been studied for its potential use as an antidepressant. Its chemical structure suggests that it may interact with neurotransmitter systems in the brain, potentially leading to mood elevation and relief from depressive symptoms.
Used as a Dopaminergic Agent:
N,N-dimethyl-3,3-diphenylpropan-1-amine has also been investigated for its potential as a dopaminergic agent. Given its structural features, it may modulate dopamine levels in the brain, which could have implications for the treatment of conditions associated with dopamine dysregulation, such as Parkinson's disease and schizophrenia.
Used in Neurological Disorder Treatment:
N,N-dimethyl-3,3-diphenylpropan-1-amine has been explored for its potential role in the treatment of neurological disorders. Its interaction with neurotransmitter systems may offer therapeutic benefits for patients suffering from various neurological conditions.
Used as a Research Tool in Neurochemistry:
In addition to its potential clinical applications, N,N-dimethyl-3,3-diphenylpropan-1-amine serves as a valuable research tool in neurochemistry. Its use in laboratory settings helps scientists better understand the mechanisms of action of neurotransmitters and the development of novel neuroactive compounds.

Check Digit Verification of cas no

The CAS Registry Mumber 4646-55-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,6,4 and 6 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 4646-55:
(6*4)+(5*6)+(4*4)+(3*6)+(2*5)+(1*5)=103
103 % 10 = 3
So 4646-55-3 is a valid CAS Registry Number.

4646-55-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name N,N-Dimethyl-3,3-diphenyl-1-propanamine

1.2 Other means of identification

Product number -
Other names N,N-Dimethyl-3,3-bis-<4-amino-phenyl>-propylamin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:4646-55-3 SDS

4646-55-3Relevant academic research and scientific papers

Development of a general non-noble metal catalyst for the benign amination of alcohols with amines and ammonia

Cui, Xinjiang,Dai, Xingchao,Deng, Youquan,Shi, Feng

supporting information, p. 3665 - 3675 (2013/03/29)

The N-alkylation of amines or ammonia with alcohols is a valuable route for the synthesis of N-alkyl amines. However, as a potentially clean and economic choice for N-alkyl amine synthesis, non-noble metal catalysts with high activity and good selectivity are rarely reported. Normally, they are severely limited due to low activity and poor generality. Herein, a simple NiCuFeOx catalyst was designed and prepared for the N-alkylation of ammonia or amines with alcohol or primary amines. N-alkyl amines with various structures were successfully synthesized in moderate to excellent yields in the absence of organic ligands and bases. Typically, primary amines could be efficiently transformed into secondary amines and N-heterocyclic compounds, and secondary amines could be N-alkylated to synthesize tertiary amines. Note that primary and secondary amines could be produced through a one-pot reaction of ammonia and alcohols. In addition to excellent catalytic performance, the catalyst itself possesses outstanding superiority, that is, it is air and moisture stable. Moreover, the magnetic property of this catalyst makes it easily separable from the reaction mixture and it could be recovered and reused for several runs without obvious deactivation. Copyright

An improved asymmetric synthetic route to a novel triple uptake inhibitor antidepressant (2S,4R,5R)-2-benzhydryl-5-((4-methoxybenzyl)amino)tetrahydro-2H- pyran-4-ol (D-142)

Gopishetty, Bhaskar,Gogoi, Sanjib,Dutta, Aloke K.

experimental part, p. 1081 - 1086 (2011/10/04)

Triple monoamine reuptake inhibitors have been implicated in the development of a new generation of antidepressants with higher efficacy than the currently existing therapies. In this paper, we have developed an alternative efficient synthetic route for triple monoamine reuptake inhibitor D-142 in 18.5% overall yield in 11 steps starting from diphenylmethane. D-142 was developed by us recently. The key step of the present synthetic strategy is the preferential formation of a bromohydrin from olefin via a cis-bromonium intermediate, which introduced significant efficiency in the overall synthesis. Furthermore, we have developed an efficient way to recycle the optically active intermediate diol back to the desired chiral epoxide.

Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: Structural factors contributing to selectivity

Shah, Jitesh R.,Mosier, Philip D.,Roth, Bryan L.,Kellogg, Glen E.,Westkaemper, Richard B.

experimental part, p. 6496 - 6504 (2009/12/06)

Histamine H1 and serotonin 5-HT2A receptors present in the CNS have been implicated in various neuropsychiatric disorders. 9-Aminomethyl-9,10-dihydroanthracene (AMDA), a conformationally constrained diarylalkyl amine derivative, has affinity for both of these receptors. A structure-affinity relationship (SAFIR) study was carried out studying the effects of N-methylation, varying the linker chain length and constraint of the aromatic rings on the binding affinities of the compounds with the 5-HT2A and H1 receptors. Homology modeling of the 5-HT2A and H1 receptors suggests that AMDA and its analogs, the parent of which is a 5-HT2A antagonist, can bind in a fashion analogous to that of classical H1 antagonists whose ring systems are oriented toward the fifth and sixth transmembrane helices. The modeled orientation of the ligands are consistent with the reported site-directed mutagenesis data for 5-HT2A and H1 receptors and provide a potential explanation for the selectivity of ligands acting at both receptors.

Hydroaminomethylation with novel Rhodium-Carbene complexes: An efficient catalytic approach to pharmaceuticals

Ahmed, Moballigh,Buch, Cathleen,Routaboul, Lucie,Jackstell, Ralf,Klein, Holger,Spannenberg, Anke,Beller, Matthias

, p. 1594 - 1601 (2008/02/04)

Starting from [{Rh(cod)Cl}2] and 1,3-dimesitylimidazole-2- ylidenes the novel [RhCl(cod)(carbene)] complexes 1-5 have been synthesized, characterized, and tested in the hydroaminomethylation of aromatic olefins. The influence of different ligands and reaction parameters on the catalytic activity was investigated in detail applying 1,1-diphenylethylene and piperidine as a model system. The scope and limitations of the novel catalysts is shown in the preparation of 16 biologically active 1-amino-3,3-diarylpropenes. In general, high chemo- and regioselectivity as well as good yields of the desired products were achieved.

Synthesis, pharmacological and biophysical characterization, and membrane-interaction QSAR analysis of cationic amphiphilic model compounds

Klein, Christian D. P.,Klingmüller, Martin,Schellinski, Christiane,Landmann, Silke,Hauschild, Stefanie,Heber, Dieter,Mohr, Klaus,Hopfinger

, p. 3874 - 3888 (2007/10/03)

Cationic amphiphilic drugs have a propensity to interact with biological interphases. This study was designed to gain more insight into the molecular properties of catamphiphilic drugs which govern this type of interaction. A series of phenylpropylamine model compounds were synthesized in which modifications were incorporated at the aromatic part of the molecule. The replacement of 45Ca2+ from phosphatidylserine monolayers served to monitor drug binding to the phospholipid. The influence on the phase- transition temperature of liposomes of dipalmitoylphosphatidic acid was measured to assess the perturbing action of the drugs on the structural organization of phospholipid assemblies. The antiarrhythmic activity of the compounds was determined in Langendorff preparations of guinea pig hearts to assess the membrane-stabilizing action. Quantitative structure-activity relationship (QSAR) models for these endpoints were developed using both intra- and intermolecular QSAR descriptors. Intermolecular membrane- interaction descriptors were derived from molecular dynamics simulations of the compounds in a model phospholipid monolayer. QSAR models were derived for all endpoints using partial least-squares regression (PLS) and a genetic algorithm tool, the genetic function approximation (GFA). Membrane- interaction descriptors appear to be of a particular importance in explaining the influence of the compounds on the phase-transition temperature of DPPA liposomes, while the other endpoints can be adequately modeled by intramolecular descriptors. The calcium-displacing activity at phosphatidylserine monolayers is governed by the electrostatic properties of the compounds. Measures of lipophilicity and molecular size are of particular importance for antiarrhythmic activity. Possible improvements to both the molecular modeling and the applied computational protocol of membrane-solute systems are identified and discussed.

Reductive electrophilic substitution of diarylmethyl methyl ethers: Synthetic applications

Azzena,Melloni,Fenude,Fina,Marchetti,Sechi

, p. 591 - 599 (2007/10/02)

The reductive cleavage of diarylmethyl methyl ethers with Li metal in THF led to quantitative formation of the corresponding diarylmethyl anions. Quenching with electrophiles afforded substituted diarylmethanes in good to excellent yields.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 4646-55-3